Skip to content
Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Latest News

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

For Investors

The Conference Call on Q3 2024 financial results took place on November 5, 2024
Healthcare innovation through technology: Augmented Reality, cloud-based data, and more >

Innovation

Healthcare innovation through technology: Augmented Reality, cloud-based data, and more
Obesity Trends, Anti-Obesity Drugs, and the Future of CKD Care >

Blog

Obesity Trends, Anti-Obesity Drugs, and the Future of CKD Care

Blog

Dr. Hippen on the Finalization of the Improving Organ Transplant Access (IOTA) Rule

Together

Living Well This Worlds Diabetes Day

Healthcare Professionals

Products, therapies and services for Healthcare Professionals

Learn more

Patients & Families

Patients & Families

Learn more

WHO WE ARE - In Full Year 2023 figures

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 4.1 million patients worldwide regularly undergo dialysis treatment.

Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the Renal Care Continuum, the company focuses on expanding in complementary areas and in the field of critical care.

~ 52 M

TREATMENTS

> 332,000

PATIENTS SERVED

~ 4,000

CLINICS

~ 40

PRODUCTION SITES

~ 120,000

EMPLOYEES